IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v492y2012i7428d10.1038_nature11691.html
   My bibliography  Save this article

Automated design of ligands to polypharmacological profiles

Author

Listed:
  • Jérémy Besnard

    (College of Life Sciences, University of Dundee, Dundee DD1 5EH, UK)

  • Gian Filippo Ruda

    (College of Life Sciences, University of Dundee, Dundee DD1 5EH, UK)

  • Vincent Setola

    (NIMH Psychoactive Drug Screening Program, The University of North Carolina Chapel Hill School of Medicine)

  • Keren Abecassis

    (College of Life Sciences, University of Dundee, Dundee DD1 5EH, UK)

  • Ramona M. Rodriguiz

    (Mouse Behavioral and Neuroendocrine Analysis Core Facility, Duke University Medical School)

  • Xi-Ping Huang

    (NIMH Psychoactive Drug Screening Program, The University of North Carolina Chapel Hill School of Medicine)

  • Suzanne Norval

    (College of Life Sciences, University of Dundee, Dundee DD1 5EH, UK)

  • Maria F. Sassano

    (The University of North Carolina Chapel Hill School of Medicine)

  • Antony I. Shin

    (Mouse Behavioral and Neuroendocrine Analysis Core Facility, Duke University Medical School)

  • Lauren A. Webster

    (College of Life Sciences, University of Dundee, Dundee DD1 5EH, UK)

  • Frederick R. C. Simeons

    (College of Life Sciences, University of Dundee, Dundee DD1 5EH, UK)

  • Laste Stojanovski

    (College of Life Sciences, University of Dundee, Dundee DD1 5EH, UK)

  • Annik Prat

    (Laboratory of Biochemical Neuroendocrinology, Clinical Research Institute of Montreal (IRCM), affiliated with the University of Montreal, Montreal, Quebec, H2W 1R7, Canada)

  • Nabil G. Seidah

    (Laboratory of Biochemical Neuroendocrinology, Clinical Research Institute of Montreal (IRCM), affiliated with the University of Montreal, Montreal, Quebec, H2W 1R7, Canada)

  • Daniel B. Constam

    (Ecole Polytechnique Fédérale de Lausanne (EPFL) SV ISREC, Station 19, CH-1015 Lausanne, Switzerland)

  • G. Richard Bickerton

    (College of Life Sciences, University of Dundee, Dundee DD1 5EH, UK)

  • Kevin D. Read

    (College of Life Sciences, University of Dundee, Dundee DD1 5EH, UK)

  • William C. Wetsel

    (Mouse Behavioral and Neuroendocrine Analysis Core Facility, Duke University Medical School
    Cell Biology, and Neurobiology, Duke University Medical School)

  • Ian H. Gilbert

    (College of Life Sciences, University of Dundee, Dundee DD1 5EH, UK)

  • Bryan L. Roth

    (NIMH Psychoactive Drug Screening Program, The University of North Carolina Chapel Hill School of Medicine
    The University of North Carolina Chapel Hill School of Medicine)

  • Andrew L. Hopkins

    (College of Life Sciences, University of Dundee, Dundee DD1 5EH, UK)

Abstract

The clinical efficacy and safety of a drug is determined by its activity profile across many proteins in the proteome. However, designing drugs with a specific multi-target profile is both complex and difficult. Therefore methods to design drugs rationally a priori against profiles of several proteins would have immense value in drug discovery. Here we describe a new approach for the automated design of ligands against profiles of multiple drug targets. The method is demonstrated by the evolution of an approved acetylcholinesterase inhibitor drug into brain-penetrable ligands with either specific polypharmacology or exquisite selectivity profiles for G-protein-coupled receptors. Overall, 800 ligand–target predictions of prospectively designed ligands were tested experimentally, of which 75% were confirmed to be correct. We also demonstrate target engagement in vivo. The approach can be a useful source of drug leads when multi-target profiles are required to achieve either selectivity over other drug targets or a desired polypharmacology.

Suggested Citation

  • Jérémy Besnard & Gian Filippo Ruda & Vincent Setola & Keren Abecassis & Ramona M. Rodriguiz & Xi-Ping Huang & Suzanne Norval & Maria F. Sassano & Antony I. Shin & Lauren A. Webster & Frederick R. C. S, 2012. "Automated design of ligands to polypharmacological profiles," Nature, Nature, vol. 492(7428), pages 215-220, December.
    • Handle: RePEc:nat:nature:v:492:y:2012:i:7428:d:10.1038_nature11691
    DOI: 10.1038/nature11691
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature11691
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/nature11691?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Jason Wallach & Andrew B. Cao & Maggie M. Calkins & Andrew J. Heim & Janelle K. Lanham & Emma M. Bonniwell & Joseph J. Hennessey & Hailey A. Bock & Emilie I. Anderson & Alexander M. Sherwood & Hamilto, 2023. "Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential," Nature Communications, Nature, vol. 14(1), pages 1-19, December.
    2. Tuomo Kalliokoski & Christian Kramer & Anna Vulpetti & Peter Gedeck, 2013. "Comparability of Mixed IC50 Data – A Statistical Analysis," PLOS ONE, Public Library of Science, vol. 8(4), pages 1-12, April.
    3. Choo Jun Tan & Siew Chin Neoh & Chee Peng Lim & Samer Hanoun & Wai Peng Wong & Chu Kong Loo & Li Zhang & Saeid Nahavandi, 2019. "Application of an evolutionary algorithm-based ensemble model to job-shop scheduling," Journal of Intelligent Manufacturing, Springer, vol. 30(2), pages 879-890, February.
    4. Richard D Cramer, 2015. "Template CoMFA Generates Single 3D-QSAR Models that, for Twelve of Twelve Biological Targets, Predict All ChEMBL-Tabulated Affinities," PLOS ONE, Public Library of Science, vol. 10(6), pages 1-22, June.
    5. Václav Havel & Andrew C. Kruegel & Benjamin Bechand & Scot McIntosh & Leia Stallings & Alana Hodges & Madalee G. Wulf & Mel Nelson & Amanda Hunkele & Michael Ansonoff & John E. Pintar & Christopher Hw, 2024. "Oxa-Iboga alkaloids lack cardiac risk and disrupt opioid use in animal models," Nature Communications, Nature, vol. 15(1), pages 1-21, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:492:y:2012:i:7428:d:10.1038_nature11691. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.